ATEX
Anterix Inc.
ATEX's fundamentals are mixed, but it looks expensive: trading at 218x earnings, about 11 times its usual 21x. Its downside scenario is more than ten times its upside.
NBIS
Nebius Group N.V.
There isn't enough reported data to score NBIS yet.
ATEX Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Strong | |
| Strong |
ATEX's revenue, profitability, cash flow and balance sheet are all currently healthy.
NBIS Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| Unavailable | |
| Healthy |
NBIS's profitability and balance sheet are currently healthy. There isn't enough data to rate its revenue and cash flow.
ATEX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.4x | $3.19 | -96% |
| Fair | 20x | $7.73 | -91% |
| Expensive | 44x | $16.81 | -80% |
| Current | 218x | $82.69 | — |
Historical ranges are pointers, not guarantees.
ATEX's PE is in its expensive range at 218x.
NBIS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 68x | $22.45 | -83% |
| Fair | 114x | $37.67 | -71% |
| Current | 390x | $129 | — |
| Expensive | 666x | $220 | +71% |
Historical ranges are pointers, not guarantees.
NBIS has the edge over ATEX in the historical PE scenario, which offers more potential upside but is not a forecast.
ATEX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| High |
Analysts expect ATEX's losses to shrink, with revenue growing.
NBIS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect NBIS's revenue to grow and its profitability to improve, with its earnings holding steady. However, they disagree widely on these estimates.
ATEX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.38 | -93% |
| Q2 2026 | $3.49 | +121% |
| Q1 2026 | $4.83 | +$5.44 |
| Q4 2025 | $4.37 | +$6.00 |
| Q3 2025 | $5.13 | +$7.15 |
| Q2 2025 | $1.58 | +$2.80 |
| Q1 2025 | -$0.61 | -$0.12 |
| Q4 2024 | -$1.63 | -294% |
ATEX's earnings per share have fallen from their peak: $0.38 over the past year, against $5.13 in late 2025.
NBIS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | $0.33 | +$2.61 |
| Q4 2024 | -$2.28 | -456% |
| Q4 2023 | $0.64 | -36% |
| Q4 2022 | $1.00 | +$1.49 |
| Q4 2021 | -$0.49 | -156% |
| Q4 2020 | $0.87 | +89% |
| Q4 2019 | $0.46 | -73% |
| Q4 2018 | $1.71 | +434% |
NBIS has the edge over ATEX in the latest year-over-year earnings comparison.
ATEX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2M | +26% |
| Q2 2026 | $2M | +38% |
| Q1 2026 | $2M | +41% |
| Q4 2025 | $1.6M | +0.4% |
| Q3 2025 | $1.6M | +0.1% |
| Q2 2025 | $1.4M | -7% |
| Q1 2025 | $1.4M | +10% |
| Q4 2024 | $1.6M | +23% |
ATEX has the edge over NBIS in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -292% | -4201 points |
| Q2 2026 | -13% | -1598 points |
| Q1 2026 | 1013% | +337 points |
| Q4 2025 | -576% | -1025 points |
| Q3 2025 | 3909% | +4756 points |
| Q2 2025 | 1585% | +2570 points |
| Q1 2025 | 676% | +1511 points |
| Q4 2024 | 449% | +373 points |
ATEX's operating margin was −292% last quarter, down 4201 points from the same quarter a year ago.
NBIS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2023 | $9.7B | +53% |
| Q4 2022 | $6.3B | +46% |
| Q4 2021 | $4.3B | +63% |
| Q4 2020 | $2.6B | +24% |
| Q4 2019 | $2.1B | +37% |
| Q4 2018 | $1.5B | +36% |
| Q4 2017 | $1.1B | +24% |
| Q4 2016 | $917M | +27% |
NBIS's revenue is growing: $530M last quarter, down 80% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -115% | -112 points |
| Q4 2023 | 3.6% | -11 points |
| Q4 2022 | 2.5% | -14 points |
| Q4 2021 | -3.7% | -18 points |
| Q4 2020 | 7.4% | -9.5 points |
| Q4 2019 | 14% | -2 points |
| Q4 2018 | 16% | -14 points |
| Q4 2017 | 14% | -19 points |
NBIS's operating margin was −115% last quarter, down 123 points from the same quarter a year ago, near the bottom of its range since 2011.
ATEX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $2M | +$5.1M |
| Q1 2026 | $15.5M | +$32.1M |
| Q4 2025 | -$8.3M | -$582K |
| Q2 2025 | -$3.1M | -$779K |
| Q1 2025 | -$16.6M | -372% |
| Q4 2024 | -$7.7M | -123% |
| Q3 2024 | -$2.7M | -126% |
| Q2 2024 | -$2.4M | +$5.9M |
ATEX's free cash flow has turned positive again: $3M over the past year, against −$30M the year before.
NBIS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$3.7B | -$3.1B |
| Q4 2024 | -$562.1M | -$316.2M |
| Q4 2023 | -$245.9M | -$138.9M |
| Q4 2022 | -$107M | +$319.7M |
| Q4 2021 | -$426.7M | -539% |
| Q4 2020 | $97.3M | -66% |
| Q4 2019 | $287.9M | +$289.2M |
| Q4 2018 | -$1.3M | -101% |
NBIS has burned cash in six of the last eight quarters: −$4.6B over the past year, against −$43M the year before.
ATEX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -31.8K shares |
| 1 year | +4.8% | +890K shares |
| 3 years | +2.5% | +486K shares |
| 5 years | +9.6% | +1.7M shares |
| Available history | +15% | +2.5M shares |
ATEX has 20M diluted shares, up 4.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $990,000 |
| Q2 2025 | — |
| Q1 2025 | $2M |
| Q4 2024 | $4.4M |
| Q3 2024 | — |
| Q2 2024 | $2M |
NBIS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -12% | -33.3M shares |
| 1 year | -32% | -115M shares |
| 3 years | -26% | -86.9M shares |
NBIS has the edge over ATEX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2024 | $10M |
| Q4 2021 | $84.1M |
| Q4 2020 | $122.8M |
| Q4 2019 | $17.2M |
| Q4 2018 | $121.8M |
| Q4 2014 | $101.7M |
| Q4 2013 | $102.9M |
ATEX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -20.6x | Net Cash |
| Q2 2026 | -1.6x | Net Cash |
| Q1 2026 | -1.0x | Net Cash |
| Q4 2025 | -0.4x | Net Cash |
| Q3 2025 | -0.4x | Net Cash |
| Q2 2025 | -1.6x | Net Cash |
| Q4 2023 | -3.6x | Net Cash |
| Q3 2023 | -6.2x | Net Cash |
ATEX has more cash than debt.
NBIS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2023 | 0.7x | Very low |
| Q4 2022 | -0.7x | Net Cash |
NBIS's net debt is less than a year of its operating earnings (EBITDA).
ATEX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.2 | Neutral |
| Stochastic | 42.7 | Neutral |
ATEX's weekly RSI is 53 (neutral) and its Stochastic is 43 (neutral).
NBIS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 8.3 | Oversold |
NBIS's weekly RSI is 38 (neutral) and its Stochastic is 8 (oversold).
ATEX PE vs Communication Services Sector
| Metric | ATEX | Sector median | Relative |
|---|---|---|---|
| PE | 218x | 16x | 1,220% above |
| PE % | 100 | 26 | 74 pts above |
ATEX has the edge over NBIS on valuation relative to its sector.
NBIS PE vs Communication Services Sector
| Metric | NBIS | Sector median | Relative |
|---|---|---|---|
| PE | 390x | 16x | 2,264% above |
| PE % | 62 | 24 | 38 pts above |
NBIS is trading at 390x earnings, a 2264% premium to the Communication Services sector's median of 16x, though its earnings don't support one.
ATEX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $81.7 | 1.2% above |
| 20 week MA | $88.4 | 6.5% below |
| 50 week MA | $60.6 | 36% above |
| 100 week MA | $43.9 | 88% above |
| 200 week MA | $38.7 | 114% above |
ATEX has stronger trend alignment. ATEX is above 4 of 5 weekly averages versus NBIS above 1 of 4.
NBIS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $179.7 | 28% below |
| 20 week MA | $199.9 | 36% below |
| 50 week MA | $163.5 | 21% below |
| 100 week MA | $110.0 | 17% above |
NBIS has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 17% above its 100-week average.
ATEX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $42.2 | $39.6 | -6.1% |
| 2021 | $39.6 | $60.1 | +52% |
| 2022 | $60.1 | $30.9 | -49% |
| 2023 | $30.9 | $33.3 | +7.9% |
| 2024 | $33.3 | $30.7 | -7.7% |
| 2025 | $30.7 | $22.0 | -28% |
| 2026 YTD | $22.0 | $82.7 | +276% |
ATEX has the edge over NBIS on returns for 2026, with the stronger performance.
NBIS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $19.6 | $27.3 | +40% |
| 2025 | $27.3 | $87.6 | +221% |
| 2026 YTD | $87.6 | $128.6 | +47% |
NBIS has finished every year since 2024 higher, and it's up 47% so far in 2026.